Diabetes Meds

HOUSTON — Harris County’s deceptive trade practices claim against several companies that manufacture diabetes medication and companies that manage pharmacy benefits for most people in the U.S. may continue, a federal court in Houston ruled. The county claims a conspiracy between the manufacturers and pharmacy benefits managers created a “secret spread” between the reported price for diabetes drugs and the “true net” price for such drugs.

Subscribe to Closing Arguments

Sign up for new weekly newsletter Closing Arguments to get the latest about ongoing trials, major litigation and hot cases and rulings in courthouses around the U.S. and the world.

Email *

Submit